Product Information
TASIMELTEON 20 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $271.2210 per EA under NDC 00480449056. Its NADAC has been published 101 times since Sep 18, 2024.
FDA first approved this application on Dec 12, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480449056
Classification
Generic
Dosage Form
CAPSULE, GELATIN COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TASIMELTEONApproval Type
Generic (ANDA)
FDA Application
ANDA211601FDA Approved
12/12/2022
TE Code
AB
On Market Since
12/29/2022
Pharmacological Classes
Price Statistics
The NADAC for TASIMELTEON 20 MG CAPSULE has been published 101 times since Sep 18, 2024, and over the history we have for it it has declined 55.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $271.2210 per EA |
|---|---|
| All-time high | $608.5590 (Sep 10, 2025) |
| All-time low | $271.2210 (Aug 19, 2026) |
| 52-week high | $608.5590 |
| 52-week low | $271.2210 |
| Median price | $608.5590 |
| Average price | $498.2103 |
| Largest weekly change | -31.1% (Sep 17, 2025) |
| Weeks tracked | 101 |
| Tracking since | Sep 18, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TASIMELTEON 20 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TASIMELTEON 20 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $271.2210 per EA (NDC 00480449056), effective Aug 19, 2026.
How has the price of TASIMELTEON 20 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TASIMELTEON 20 MG CAPSULE has declined 55.4%. It has been tracked across 101 weekly CMS publications since Sep 18, 2024.
What are the highest and lowest recorded NADAC prices for TASIMELTEON 20 MG CAPSULE?
Since Sep 18, 2024, the NADAC for TASIMELTEON 20 MG CAPSULE has ranged from a low of $271.2210 (Aug 19, 2026) to a high of $608.5590 (Sep 10, 2025), with a median of $608.5590 per EA.
Are there cheaper alternatives to TASIMELTEON 20 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TASIMELTEON 20 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures TASIMELTEON 20 MG CAPSULE?
TASIMELTEON 20 MG CAPSULE (NDC 00480449056) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.